TABLE 3.

Low‐risk patient 30‐day safety and effectiveness events in the post‐implementation cohort

	Older adult (≥65 years)	Middle‐aged (46–64 years)	Young (21–45 years)
	N = 97 (%)	N = 683 (%)	N = 681 (%)
	n (%, 95% CI)	n (%, 95% CI)	n (%, 95% CI)
Safety
Death	2 (2.1, 0.4–8.0)	1 (0.1, 0–0.9)	1 (0.1, 0–1.0)
MI	0 (0, 0–4.8)	1 (0.1, 0–0.9)	1 (0.1, 0–1.0)
Revascularization	0 (0, 0–4.8)	1 (0.1, 0–0.9)	1 (0.1, 0–1.0)
Death + MI	2 (2.1, 0.4–8.0)	2 (0.3, 0.1–1.2)	2 (0.3, 0.1–1.4)
MACE (Death + MI + Revasc)	2 (2.1, 0.4–8.0)	3 (0.4, 0.1–1.4)	2 (0.3, 0.1–1.4)
Effectiveness
Hospitalization	29 (29.9, 21.2–40.2)	136 (19.9, 17.0–23.1)	103 (15.1, 12.6–18.1)
Objective cardiac testing	15 (15.5, 9.2–24.5)	87 (12.7, 10.4–15.5)	54 (7.9, 6.0–10.3)
Early discharge	72 (74.2, 64.2–82.3)	554 (81.1, 77.9–83.9)	577 (84.7, 81.8–87.3)

Abbreviation: MI, myocardial infarction.